Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
about
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activityMolecular responses to hypoxia in tumor cellsFunctions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathyDisruptive environmental chemicals and cellular mechanisms that confer resistance to cell deathIndependent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylationMolecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivoHuman alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndromeThe B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor modelsMiniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic responseHIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle.Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.A new procedure for determining the genetic basis of a physiological process in a non-model species, illustrated by cold induced angiogenesis in the carpEupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling.Desferrioxamine regulates HIF-1 alpha expression in neonatal rat brain after hypoxia-ischemiaBrucine suppresses colon cancer cells growth via mediating KDR signalling pathway.Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival.Indirubin derivative E804 inhibits angiogenesis.The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia5-Formylhonokiol exerts anti-angiogenesis activity via inactivating the ERK signaling pathway.Capillary Network-Like Organization of Endothelial Cells in PEGDA Scaffolds Encoded with Angiogenic Signals via Triple Helical Hybridization.Calcium-activated K+ channels increase cell proliferation independent of K+ conductance.Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy.Plant proteolytic enzyme papain abrogates angiogenic activation of human umbilical vein endothelial cells (HUVEC) in vitro.Hypoxia-inducible factor in thyroid carcinomaMechanism and its regulation of tumor-induced angiogenesis.Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional eventsNeuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801.Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment.Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathwayDisordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null miceEndothelial FAK is required for tumour angiogenesisA novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylationEffects of PI3K and p42/p44 MAPK on overexpression of vascular endothelial growth factor in hepatocellular carcinoma.Current insights on the biology and clinical aspects of VEGF regulation.
P2860
Q24303868-B4A20F41-E0CD-42C7-8FC1-25FD7455769DQ24797310-E6341313-6197-4F71-9F05-243357B33606Q26824541-A53765A2-246A-4032-94D9-058C81C716E7Q28080874-2FB0C681-F345-4CD3-A899-D6B38F62DE8FQ28188357-54615454-F725-4102-B598-97F7AEBA7E1BQ28211299-35F19DDA-229B-4871-9037-BFD303834DE4Q28271413-580A3721-60E4-4045-B7AD-FB71421208B8Q28571767-630D7F13-A7E7-4B30-A650-FEC12153DAC3Q28744228-BD2EBA52-82D9-4BFB-9F98-A697836FC199Q28831172-2EB6EAC2-D66C-44C5-9267-E4291D3D3D41Q30832574-D3E5E203-FF96-4297-9168-5BA520BEC6FAQ31007381-E388F38B-787A-46C1-9102-9C5E4557729CQ33512121-EFE674A1-8BE6-4589-BC55-AEF8AA6B6EBCQ33827192-F3F66A9A-61F8-41BB-987D-19A064E3E027Q33961956-AECCEDBF-750B-4C1D-8691-4FE0869D71F4Q34154752-F7835DAD-3251-4C08-A7BA-A7C178E7451AQ34173738-91FE391B-548B-4882-8E3F-9EC7392E0A6FQ34254864-42250F72-4F01-40E3-B452-72D8038E7FC7Q34324270-A0D685B0-FE8D-4E4C-9CEB-7D3FCC2CCB3CQ34745159-CD2C1CB0-18A5-44D4-8C73-4BD845441F91Q34756553-CFD99BC5-8CB6-4CB8-AF48-1C7AE353BE72Q34782159-468633BC-379C-461F-AE17-05BE4BBBE56FQ34973413-A7D411F0-A0B8-41F7-AF47-F0CE0BD7CEF9Q34992804-A26EB389-EDAE-4764-A7DC-2DFCFFF9B741Q35099457-CA7A6041-14EE-413F-A4B4-D1BB4A85F978Q35151099-8BEB4CD1-FE87-4296-A815-A1F3D8B4C7E5Q35197405-ACE5DDA6-FD30-4C2C-9333-D6C064E204B2Q35216474-C90E70B9-A3CB-4EC6-B256-B841CF7E98CDQ35291703-CC6C8C50-F1E4-4B25-A4CD-8697BB097CDEQ35607396-6D13F8B0-0FFA-47BB-B15D-CAACCE7EF047Q35850665-1BD4D6D5-FAE0-4E6F-B6BA-68F495FF695CQ35857448-63A75316-B748-47AC-A4CD-973218DF16ECQ35992390-0005C357-7784-46E5-BD80-3325B7805CBDQ36007505-74DDCDFA-B897-42A2-8E4D-10949211BDD3Q36039352-DFF84A2F-4F84-495B-B86C-58C4446D0B1CQ36279494-80E1F461-859B-4F8F-9FD7-CC7B38D08756Q36307866-80E01A5E-72CA-4009-B894-9ED73808192FQ36347241-9D2DBF18-0A8E-477A-92A0-E573A472479CQ36502607-639B645F-CFD7-4DF7-B1B8-3AA98F36F8B3Q37272329-BE511A79-F1C5-4FE3-A8DC-767437B91966
P2860
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@ast
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@en
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@nl
type
label
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@ast
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@en
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@nl
prefLabel
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@ast
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@en
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@nl
P2093
P1476
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.
@en
P2093
D E Richard
P304
P356
10.1016/S0006-2952(00)00423-8
P407
P577
2000-10-01T00:00:00Z